MedTrace Logo

The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

NCT00481585 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2014-02-04

No results posted yet for this study

Summary

The objective of the present study is to determine whether or not primary human mammary epithelial cells are competent for use in molecular studies of transepithelial electrophysiology focusing on the function of the tight junction protein claudin 3.

Human breast Tissue will be removed from mastectomy specimens and used as a source to generate epithelial cells for study.

Conditions

Sponsors & Collaborators

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • Erik F Young, Ph.D. · Hackensack Meridian Health

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00481585 on ClinicalTrials.gov